SANOFI CONSUMER HEALTHCARE INDIA
|
The Current P/S Ratio of SANOFI CONSUMER HEALTHCARE INDIA is 11.14.
| Share Price | ₹4,527.3 | May 27,2026 |
| Market Cap | ₹10,412.8 Cr | |
| Sales-TTM | ₹935.0 Cr | TTM-Standalone Results |
| Price/Sales | 11.14x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SANOFI CONSUMER HEALTHCARE INDIA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹10,412.8 Cr] as on May 27,2026
(/) Sales [ ₹935.0 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 11.14x ]
Thus, for SANOFI CONSUMER HEALTHCARE INDIA , the investors are currently willing to pay '11.14 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SANOFI CONSUMER HEALTHCARE INDIA !
The chart below summarizes the trend in P/S Ratio of SANOFI CONSUMER HEALTHCARE INDIA over the last five years.
Historical PS (Price/Sales) ratio chart of SANOFI CONSUMER HEALTHCARE INDIA
PS Ratio Performance Analysis for SANOFI CONSUMER HEALTHCARE INDIA
- SANOFI CONSUMER HEALTHCARE INDIA 's p/e ratio for fiscal years ending Dec2024 to Dec2023 averaged 7.82x.
- SANOFI CONSUMER HEALTHCARE INDIA 's operated at median p/e ratio of 15.64x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, SANOFI CONSUMER HEALTHCARE INDIA 's p/e ratio peaked in Dec2024 at 15.64x.
- SANOFI CONSUMER HEALTHCARE INDIA 's p/e ratio hit its five-year low in Dec2023 of 0x.
How does SANOFI CONSUMER HEALTHCARE INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SANOFI CONSUMER HEALTHCARE INDIA | 935.0 | 11.14 | 10,412.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.57 | 442,677.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 17.09 | 180,458.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 10.99 | 153,685.0 |
| CIPLA LTD | 28,162.6 | 4.07 | 114,562.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.27 | 110,095.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.00 | 99,957.1 |
| LUPIN LTD | 27,958.0 | 3.72 | 104,097.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.02 | 109,272.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.45 | 82,604.1 |
| LAURUS LABS LTD | 6,812.9 | 10.94 | 74,562.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SANOFI CONSUMER HEALTHCARE INDIA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.45x |
| Max industry PS | 17.09x |
| Median industry PS | 7.00x |
| Average industry PS | 7.48x |
You may also like the below Video Courses